IP Library Granted Patent US 9,410,040
Granted Patent B2
US 9,410,040 · App. 13/520,735 · Granted Aug 9, 2016

Soluble graphene nanostructures and assemblies therefrom

Inventors: Liang-shi Li (Bloomington, IN); Xin Yan (Bloomington, IN)
Assignee: Indiana University Research and Technology Corporation
C09C1/44C01B31/0438C01P2002/82C01P2002/89C01P2006/40Y10T428/265
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,410,040
App. No.
13/520,735
Granted
Aug 9, 2016
Kind
B2
Abstract

Disclosed herein is a method for preparing large soluble graphenes. The method comprises attaching one or more hindering groups to the graphene, which can prevent face-to-face graphene stacking by reducing the effects of inter-graphene attraction. The large graphenes can absorb a wide spectrum of light from UV to near infrared, and are useful in photovoltaic devices and sensitizers in nanocrystalline solar cells.

Claims (16)

1. A composition comprising a population of graphene quantum dots, the quantum dots comprising graphene having a sheet structure, wherein the sheet structure has a sheet length from about 1 nanometer to about 4 nanometers and a sheet width from about 0.05 nanometers to about 5 nanometers, and an encapsulating means for solubilizing the graphene to prevent aggregation so that the population of graphene quantum dots remains solvated in a solution, wherein the encapsulating means comprises a steric hindering group of the formula

covalently linked to the graphene, wherein A 1 , A 2 and A 3 are each independently alkyl, alkenyl, alkynyl, cycloalkyl, heteroalkyl, or cycloheteroalkyl, and wherein the encapsulating means forms a three-dimensional cage structure.

2. The composition of claim 1 , wherein the solution is an organic solvent.

3. The composition of claim 2 , wherein the organic solvent is a non-polar organic solvent.

4. The composition of claim 2 , wherein the composition has a solubility maximum in a non-polar solvent of from about 10 mg/mL to about 100 mg/mL.

5. The composition of claim 2 , wherein the composition has a solubility maximum in a non-polar solvent of from about 20 mg/mL to about 70 mg/mL.

6. The composition of claim 2 , wherein the composition has a solubility maximum in a non-polar solvent of from about 25 mg/mL to about 50 mg/mL.

7. The composition of claim 2 , wherein the organic solvent is a non-polar organic solvent selected from the group consisting of chloroform, dichloromethane, toluene and THF.

8. A composition comprising a population of graphene nanostructures, the nanostructures comprising graphene having a ribbon structure, wherein the ribbon structure has a ribbon length from about 2 nanometers to about 2 centimeters and a ribbon width from about 0.5 nanometers to about 5 nanometers, and an encapsulating means for solubilizing the graphene to prevent aggregation so that the population of graphene quantum dots remains solvated in a solution, wherein the encapsulating means comprises a steric hindering group of the formula

covalently linked to the graphene, wherein A 1 , A 2 and A 3 are each independently alkyl, alkenyl, alkynyl, cycloalkyl, heteroalkyl, or cycloheteroalkyl, and wherein the encapsulating means forms a three-dimensional cage structure.

9. The composition of claim 8 , wherein the solution is an organic solvent.

10. The composition of claim 9 , wherein the organic solvent is a non-polar organic solvent.

11. The composition of claim 9 , wherein the composition has a solubility maximum in a non-polar solvent of from about 10 mg/mL to about 100 mg/mL.

12. The composition of claim 9 , wherein the composition has a solubility maximum in a non-polar solvent of from about 20 mg/mL to about 70 mg/mL.

13. The composition of claim 9 , wherein the composition has a solubility maximum in a non-polar solvent of from about 25 mg/mL to about 50 mg/mL.

14. The composition of claim 9 , wherein the non-polar organic solvent is selected from chloroform, dichloromethane, toluene and THF.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jul 13, 2012
From: INDIANA UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 028553/0869 →
Continuity (2)
Provisional Application 61293337 · Jan 8, 2010
Related Publication 20120279570A1 · Nov 8, 2012